SightfileU.S. market data from official filings

REVVITY INC (RVTY)

Name: REVVITY INC (RVTY) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000031791 · EDGAR filings · Updated 2026-07-22

REVVITY INC (RVTY) has reported institutional ownership of 103.5%, with 497 institutional managers holding positions valued at $10.1B per the latest 13F reporting period.

Institutional ownership

103.5%

Institutional managers

497

Reported 13F value

$10.1B

Insider activity

65 trans.

−$4.77M net selling

Filings this week (1)

2026-07-22 — Insider transaction reported (Form 4)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-20 — Notice of proposed sale filed (Form 144)
2026-07-20 — 25-NSE filed
2026-06-23 — 11-K filed
2026-06-17 — Insider transaction reported (Form 4)
2026-06-01 — SD filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, REVVITY INC has 497 institutional holders and institutional ownership of 103.5%.

Insider activity

Insiders reported 65 transactions (0 buys, 14 sells) across 15 reporting insiders, with a net reported value of −$4.77M.

Related companies

ENSIGN GROUP INC (ENSG) · BIOMARIN PHARMACEUTICAL INC (BMRN) · BEONE MEDICINES LTD (ONC) · SANOFI SA (SNY) · CYTOKINETICS INC (CYTK) · DAVITA INC (DVA)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-22.